CONNECTIVITY

FRICTIONLESS ENGAGEMENT: HOW GX INMONIT™ CAN SIMPLIFY SELF-INJECTION AND STRENGTHENS PATIENT ADHERENCE

Dr Giacomo Bruno and Simon Buerdel consider the causes of patient non-adherence and its subsequent effects on healthcare systems, going on to present the solutions created by Gerresheimer to address the patient experience across treatment types.

INTEGRATING DIGITAL HEALTH SYSTEMS INTO MEDICAL DEVICE ECOSYSTEMS: CONSIDERATIONS & STRATEGIES

Jerzy Wojcik and Liat Shochat take a look at how digital health technologies are transforming the pharmaceutical and combination product sectors. They consider the challenges in bringing these technologies to market and how the full potential of connected health technologies can be achieved.

Interview: Enhancing Clinical Trials with CliniPilot<sup>®</sup> and Clear to Clinic™ Programme

Dr Carolina Canapè

Interview: Enhancing Clinical Trials with CliniPilot^® and Clear to Clinic™ Programme

Dr Carolina Canapè and Roger Lüscher talk with Guy Furness about the application of connectivity in decentralised trials, and how Ypsomed’s CliniPilot and the company’s range of clinic-ready autoinjectors support faster, more efficient and more effective clinical trials.

Interview: Developing Wearable Injectors

EdgeOne Medical

Interview: Developing Wearable Injectors

Liat Shochat discusses her extensive experience in wearable drug delivery device development, covering the various challenges that arise from the inherent complexity of these devices, even with multiple successful wearable devices on the market, as well as the best way to engage with contract development organisations such as EdgeOne Medical.

Interview: DARE IDDS – A Long-Term Subcutaneously Implanted Drug Delivery Device

Daré Bioscience

Interview: DARE IDDS – A Long-Term Subcutaneously Implanted Drug Delivery Device

Liz Proos and Ashley Hawson talk exclusively with ONdrugDelivery's Guy Furness about the DARE Intelligent Drug Delivery System – an advanced, connected implantable device that delivers programmable doses for up to a decade – its place in the market, the challenges faced during its design and its potential as novel drug delivery device.

ORBITAL: A NOVEL HIGH-PAYLOAD, MULTI-BREATH DPI POISED FOR CLINICAL ADVANCEMENT

ORBITAL: A NOVEL HIGH-PAYLOAD, MULTI-BREATH DPI POISED FOR CLINICAL ADVANCEMENT

David Farrow, Jonathan Mulpas and Solange Le Nuz discuss the patient-centric and data-driven development of Aptar Pharma’s Orbital dry powder inhaler platform, tracing its evolution from an initial concept to a clinically-ready device.

NAVIGATING THE REGULATORY PATHWAY FOR NEXT-GENERATION NEBULISERS IN COMBINATION WITH BIOLOGICS

Edgar Hernan Cuevas Brun

HCmed Innovations

NAVIGATING THE REGULATORY PATHWAY FOR NEXT-GENERATION NEBULISERS IN COMBINATION WITH BIOLOGICS

Edgar Hernan Cuevas Brun discusses the role of nebulisers in delivering larger doses of fragile biologics, delving into the global regulatory landscape that must be understood in order to deliver these drugs on the market.

Interview: Steven Kaufman. Delivering the Future – Inside the World of Autoinjector Innovation

Portal Instruments

Interview: Steven Kaufman. Delivering the Future – Inside the World of Autoinjector Innovation

Steven Kaufman talks with ONdrugDelivery’s Guy Furness about the world of autoinjectors, looking at the current status quo in the industry, using Portal’s PRIME Nexus™ smart reusable electromechanical autoinjector as a lens to bring into focus how things have changed and where they might be going.

CUSTOM METAL SOLUTIONS FOR EMERGING CHALLENGES IN AUTOINJECTOR SYSTEMS

PREFILLED SYRINGES

CUSTOM METAL SOLUTIONS FOR EMERGING CHALLENGES IN AUTOINJECTOR SYSTEMS

Iker Ibisate, Álvaro García Nograro and Irakusne Incierte, address the complex manufacturing challenges posed by increasingly sophisticated autoinjector devices and introduce RPK Medical’s approach as a technical partner in overcoming these challenges through the tailored design and manufacture of functional metal components, such as precision springs and stamped parts.

NAVIGATING SEMICONDUCTOR LIFECYCLE CHALLENGES IN MEDTECH: A STRATEGIC SHIFT TOWARDS ASICs

NAVIGATING SEMICONDUCTOR LIFECYCLE CHALLENGES IN MEDTECH: A STRATEGIC SHIFT TOWARDS ASICs

Andy Kelly considers the evolution of semiconductor technology and the impact of the release of new and upgraded components. This article discusses how strategic decisions during the early stages of product design can determine the future viability of a medical device and considers the cost savings offered by application-specific integrated circuits through a reduction in the number of components required.

CONNECTED BUT PROTECTED – SECURELY CONNECTING DRUG DELIVERY DEVICES

Dr Joachim Wilke

CONNECTED BUT PROTECTED – SECURELY CONNECTING DRUG DELIVERY DEVICES

Dr Joachim Wilke discusses wireless connectivity in novel drug delivery devices, highlighting the possibilities for improved patient outcomes and care, the associated security risks, as well as examining the wide range of cyber security solutions and standards to mitigate these issues.

SMART ENOUGH: DESIGNING DRUG DELIVERY DEVICES THAT PUT PATIENTS FIRST

SMART ENOUGH: DESIGNING DRUG DELIVERY DEVICES THAT PUT PATIENTS FIRST

Andy Pidgeon challenges the assumption that more advanced technology is always better, re-examining the design approach to connected autoinjectors from the patient perspective and highlighting the value of simplicity and usability – digging into the idea that, by investigating the real-world needs of patients, drug delivery device designers can ensure that their devices are serving those needs, rather than creating unnecessary new challenges for users.

Interview: PDA Miniverse and Trends in Injectable Drug Delivery

Mathias Romacker

Interview: PDA Miniverse and Trends in Injectable Drug Delivery

In this exclusive interview, Mathias Romacker and Evan Edwards talk with ONdrugDelivery’s Guy Furness about the upcoming inaugural PDA Miniverse conference in Indianapolis, and the topics and trends currently being felt across the injectable drug delivery industry.

A Sustainable Future for Self-Injection with Connected, Reusable Autoinjectors

Dr Patrick Anquetil

Portal Instruments

A Sustainable Future for Self-Injection with Connected, Reusable Autoinjectors

In this exclusive interview with ONdrugDelivery’s Guy Furness, Dr Patrick Anquetil offers insight into the extensive waste involved in the self-injection market. He explains how pivoting from a model focused on fully disposable devices to reusable electromechanical autoinjectors could offer a more sustainable and cost-effective path forward.

EMPOWERING PHARMA WITH INNOVATIVE INFUSION TECHNOLOGIES AMID US POLICY CHANGES

EMPOWERING PHARMA WITH INNOVATIVE INFUSION TECHNOLOGIES AMID US POLICY CHANGES

Mindy Katz and Michael Ratigan outline the implications for pharmaceutical manufacturers of recent US policy changes – and highlight how Eitan Medical’s portfolio of infusion solutions can offer support.

VERSATILITY, SUSTAINABILITY AND DIGITALISATION IN ONE SMART HANDHELD INJECTION PLATFORM

VERSATILITY, SUSTAINABILITY AND DIGITALISATION IN ONE SMART HANDHELD INJECTION PLATFORM

Leonard Chu discusses three trends in self-administration that are aligned with emerging smart devices – device versatility, sustainability and digitalisation – and the benefits offered by the Alcee injection platform.

Interview: Pharmapack Start-up Spotlight: InnoMedica Accelerating Trials with Novel Nanoparticle Filling

Pascal Halbherr

Interview: Pharmapack Start-up Spotlight: InnoMedica Accelerating Trials with Novel Nanoparticle Filling

Pascal Halbherr discusses the InnoMedica's innovative nanocarrier filling technology platform, its impact on biotech and drug delivery, and the company’s bold vision for the future. InnoMedica, a Swiss biotech, is one of the 28 early-stage companies presenting cutting-edge innovations in Pharmapack Europe 2025’s Start-up Market.

CUSTOM INTEGRATED CIRCUITS ENABLING ADVANCEMENTS IN IMPLANTABLE DRUG DELIVERY SYSTEMS

Dr Asheesh Divetia

CUSTOM INTEGRATED CIRCUITS ENABLING ADVANCEMENTS IN IMPLANTABLE DRUG DELIVERY SYSTEMS

Asheesh Divetia looks at how custom electronics are advancing implantable drug delivery systems – with precise drug administration, seamless connectivity to other devices and real-time monitoring of drug levels and patient responses.

NAVIGATING THE AI REVOLUTION IN THE MEDICAL DEVICES SECTOR: BETWEEN INNOVATION AND REGULATION

NAVIGATING THE AI REVOLUTION IN THE MEDICAL DEVICES SECTOR: BETWEEN INNOVATION AND REGULATION

Timothy Bubb discusses the potential impact of artificial intelligence and machine learning on the healthcare and drug delivery industries, with an overview of the differing regulatory approaches taken by the EU, US FDA and UK MHRA towards this novel area of digital health.

FUTURE-PROOFING YOUR DRUG DELIVERY DEVICE: CONSIDERATIONS FOR EFFECTIVE DESIGN

INDUSTRIALISATION

Lorenzo Vaccarella

Paragon Medical

FUTURE-PROOFING YOUR DRUG DELIVERY DEVICE: CONSIDERATIONS FOR EFFECTIVE DESIGN

Lorenzo Vaccarella highlights six critical areas to consider early in the drug delivery device development journey. He discusses how strategically investing time during the early stages of the design cycle and throughout development can ultimately save both time and cost down the road when the product is being manufactured and deployed into the market.

DIGITAL TWINS – A RAPIDLY GROWING TREND IN HEALTHCARE

NXP Semiconductors

DIGITAL TWINS – A RAPIDLY GROWING TREND IN HEALTHCARE

Sylvia Kaiser-Kershaw, Susanne Hazrati and Sebastian Muenscher examine how digital twinning, based on smart and secure wirelessly connected tags and labels, can transform healthcare processes.

SMART MEMS CAP FOR SHARPS WASTE: A SIMPLE AND ELEGANT SOLUTION TO CLINICAL TRIAL ADHERENCE MONITORING

SMART MEMS CAP FOR SHARPS WASTE: A SIMPLE AND ELEGANT SOLUTION TO CLINICAL TRIAL ADHERENCE MONITORING

Frank Leipold and Bernard Vrijens discuss Haselmeier & AARDEX’ s collaboration to develop the MEMS Smart Cap – a smart solution for data collection during clinical trials to enable an accurate assessment of participant nonadherence.

DIGITAL SELF-CARE – SOLVING PATIENT CHALLENGES WHILE DELIVERING BUSINESS INSIGHTS TO PHARMA

Dr Stefanie Seiler

DIGITAL SELF-CARE – SOLVING PATIENT CHALLENGES WHILE DELIVERING BUSINESS INSIGHTS TO PHARMA

Stefanie Seiler and Ventsislav Dobrev discuss self-care challenges for patients and highlight how Ypsomed Digital Health’s solutions can solve them while also delivering meaningful business insights for pharmaceutical companies.

OPTIMISING INHALATION ADHERENCE AND TECHNIQUE: THE POWER OF DIGITAL TECHNOLOGY

Dr Carola Fuchs

OPTIMISING INHALATION ADHERENCE AND TECHNIQUE: THE POWER OF DIGITAL TECHNOLOGY

Carola Fuchs and Rupa Ram discuss the development of PARI’s new eFlow Integrated Nebuliser and the PARI Breath Guide app, and how integrating these into the PARI Connect Platform will stimulate increased adherence to inhaled therapy and, therefore, improved therapeutic outcomes.

Interview with DEAN MINNOCK

Dr Dean Minnock

Interview with DEAN MINNOCK

Guy Furness and Dean Minnock discuss Innovation Zed’s unique origin story and digital connectivity add-on for injection pens. They dive into the value of digital ecosystems in the drug delivery industry and look towards the future as the company prepares to launch its third-generation add-on technology – DOSE.

BRINGING DIGITAL HEALTH AND DRUG DELIVERY TOGETHER TO SUPPORT SUBCUTANEOUS INJECTION IN ONCOLOGY

Aptar Digital Health

BRINGING DIGITAL HEALTH AND DRUG DELIVERY TOGETHER TO SUPPORT SUBCUTANEOUS INJECTION IN ONCOLOGY

Damien McKeon and Sueyoung Yoon discuss the trends driving interest in subcutaneous administration, the barriers to overcome and the characteristics of a patient-centric solution.

1
2
3
…
14
Next

Top